Audiken Medical Limited 14798131 false 2023-04-13 2024-04-30 2024-04-30 The principal activity of the company is Other business support service activities not elsewhere classified Digita Accounts Production Advanced 6.30.9574.0 true true 14798131 2023-04-13 2024-04-30 14798131 2024-04-30 14798131 core:RetainedEarningsAccumulatedLosses 2024-04-30 14798131 core:ShareCapital 2024-04-30 14798131 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 14798131 core:OfficeEquipment 2024-04-30 14798131 bus:SmallEntities 2023-04-13 2024-04-30 14798131 bus:AuditExemptWithAccountantsReport 2023-04-13 2024-04-30 14798131 bus:FilletedAccounts 2023-04-13 2024-04-30 14798131 bus:SmallCompaniesRegimeForAccounts 2023-04-13 2024-04-30 14798131 bus:Director1 2023-04-13 2024-04-30 14798131 bus:PrivateLimitedCompanyLtd 2023-04-13 2024-04-30 14798131 core:OfficeEquipment 2023-04-13 2024-04-30 14798131 core:PlantMachinery 2023-04-13 2024-04-30 14798131 countries:AllCountries 2023-04-13 2024-04-30 iso4217:GBP xbrli:pure

Registration number: 14798131

Audiken Medical Limited

Unaudited Financial Statements

for the Period from 13 April 2023 to 30 April 2024

 

Audiken Medical Limited

(Registration number: 14798131)

Balance Sheet as at 30 April 2024

Note

2024
£

Fixed assets

 

Tangible assets

3

734

Current assets

 

Cash at bank and in hand

 

6,754

Creditors: Amounts falling due within one year

4

(2,455)

Net current assets

 

4,299

Net assets

 

5,033

Capital and reserves

 

Called up share capital

100

Retained earnings

4,933

Shareholders' funds

 

5,033

For the financial period ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Director's Report and the Profit and Loss Account has been taken.

These financial statements, which have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006 and in accordance with the provisions of FRS 102 Section 1A Small Entities, were approved and authorised for issue by the director on 7 February 2025
 

.........................................

Mrs Joanne Brentnall

Director

 

Audiken Medical Limited

Notes to the Unaudited Financial Statements for the Period from 13 April 2023 to 30 April 2024

1

Accounting policies

Statutory information

Audiken Medical Limited is a private company, limited by shares, domiciled in England and Wales, company number 14798131. The registered office is at 5 Sidings Court, White Rose Way, Doncaster, DN4 5NU.

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value. The presentation currency is United Kingdom pounds sterling, which is the functional currency of the company. The financial statements are those of an individual entity.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and work has been completed.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Audiken Medical Limited

Notes to the Unaudited Financial Statements for the Period from 13 April 2023 to 30 April 2024 (continued)

1

Accounting policies (continued)

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

33% straight line

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

3

Tangible assets

Office equipment
£

Total
£

Cost

Additions

1,095

1,095

At 30 April 2024

1,095

1,095

Depreciation

Charge for the period

361

361

At 30 April 2024

361

361

Carrying amount

At 30 April 2024

734

734

 

Audiken Medical Limited

Notes to the Unaudited Financial Statements for the Period from 13 April 2023 to 30 April 2024 (continued)

4

Creditors

Creditors: amounts falling due within one year

2024
£

Due within one year

Taxation and social security

1,055

Accruals and deferred income

1,200

Other creditors

200

2,455